Business
AmeriCann CEO to Speak at Cannabis Advancement Series Hosted at the University of Massachusetts
AmeriCann CEO to Speak at Cannabis Advancement Series Hosted at the University of Massachusetts.
About this update from Americann Inc.
[{"type":"text","content":"DENVER, CO / ACCESSWIRE / October 24, 2019 / AmeriCann, Inc. (OTCQB:ACAN), a cannabis company that has developed state-of-the-art cultivation, processing and product manufacturing facilities, announced today that Tim Keogh, its CEO, will moderate a panel at the Cannabis Advancement Series (CAS) at UMass Dartmouth. The event is being held on October 26, 2019, at the UMass Dartmouth Charlton College of Business at 285 Westport Road, Dartmouth, MA, from 5:30-9:30 pm.Mr. Keogh will be leading a focused discussion on promoting innovation and inclusion in the cannabis industry. Panelists will consist of representatives from cannabis businesses that have built these values into their framework and work to make the industry a diverse and progressive space.The keynote speaker will be Chairman Steve Hoffman from the Massachusetts Cannabis Control Commission, who will cover the Commonwealth's commitment to social equity, veteran entrepreneurship, and social justice.AmeriCann recently completed Building 1 of the Massachusetts Cannabis Center (MCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts cannabis market. The MCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced facilities in the nation.Building 1 is a 30,000 square foot cultivation and processing facility, 100% of which will be occupied by Bank, Inc. AmeriCann has a 15-year Joint-Venture partnership with Bask, Inc. which provides AmeriCann with a 15% Revenue Participation Fee of all products produced at Building 1. For a recent update on MCC construction, follow this LINK.As the first approved adult-use cannabis market on the Eastern U.S., Massachusetts has the potential to become the epicenter for cannabis innovation and research. Since November 1st, 2018, Massachusetts recreational dispensaries have sold more than $316 million worth of cannabis products. Annual recreational retail sales are expected to total $1.3 billion - $1.6 billion, according to Marijuana Business Daily.About AmeriCannAmeriCann (OTCQB: ACAN) is a cannabis company that is developing cultivation, processing and product manufacturing facilities.AmeriCann uses greenhouse technology which is superior to the current industry standard of growing cannabi...